Drug Detail

Drug Name Ribociclib
Trade Name Kisqali
Synonyms LEE011
Drug Descriptions

Kisqali (ribociclib) is a dual CDK4/6 inhibitor, which may induce cell cycle arrest and reduce proliferation in cancer cells (PMID: 24045179). Kisqali (ribociclib) is FDA-approved in combination with an aromatase inhibitor in women with hormone receptor-positive, ERBB2 (HER2)-negative breast cancer, and in combination with Faslodex (fulvestrant) in postmenopausal women with hormone receptor-positive, ERBB2 (HER2)-negative breast cancer (FDA.gov).

DrugClasses CDK4/6 Inhibitor 8

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Therapy Description
Ribociclib + H3B-5942
Ribociclib Kisqali (ribociclib) is a dual CDK4/6 inhibitor, which may induce cell cycle arrest and reduce proliferation in cancer cells (PMID: 24045179). Kisqali (ribociclib) is FDA-approved in combination with an aromatase inhibitor in women with hormone receptor-positive, ERBB2 (HER2)-negative breast cancer, and in combination with Faslodex (fulvestrant) in postmenopausal women with hormone receptor-positive, ERBB2 (HER2)-negative breast cancer (FDA.gov).
Docetaxel + Filgrastim + Prednisone + Ribociclib
Ribociclib + Mercaptopurine
LSZ 102 + Ribociclib
Ribociclib + Dexamethasone
Ribociclib + Letrozole + Goserelin
Ribociclib + Sonidegib
Ribociclib + Everolimus
PDR001 + Ribociclib
Binimetinib + Ribociclib
Anastrozole + Ribociclib
Fulvestrant + Ribociclib
LEE011 + Exemestane
Ribociclib + JQ1
Ceritinib + LEE011
Ribociclib + Methotrexate
LEE011 + BYL719 + Letrozole
Doxorubicin + Ribociclib
Nazartinib + Ribociclib
LEE011 + Carboplatin + Paclitaxel
Ribociclib + Asparaginase
HDM201 + LEE011
Ribociclib + Trametinib
BKM120 + Fulvestrant + LEE011
Ribociclib + Prednisolone
Encorafenib + Ribociclib
Gemcitabine + Ribociclib
Fulvestrant + PDR001 + Ribociclib
LEE011 + Everolimus + Exemestane
Letrozole + Ribociclib
Paclitaxel + Ribociclib
LEE011 + BKM120 + Letrozole
LEE001 + Tamoxifen
Binimetinib + Encorafenib + Ribociclib
BYL719 + Fulvestrant + LEE011
Ribociclib + Bicalutamide
Filgrastim + Gemcitabine + Pegfilgrastim + Ribociclib
BYL719 + LEE011
Ribociclib + Bortezomib
Dexamethasone + Everolimus + Ribociclib
Ribociclib + Everolimus + Letrozole